Cost for blood pressure drug surges in United States after callback

NEW YORK (Reuters) – prices for two doses of blood pressure drug valsartan he put more than any other drug in the United States in September, after a recall of a large part of Supply of medicines.

Chinese pharmaceutical ingredients manufacturer Zhejiang Huahai pharmaceutical by consumers in the United States reminds in July after searching for traces of valsartan by probably carcinogenic.

according to the national average drug acquisition costs (NADAC) for last month, prices of 160 mg and 80 mg tablets of the drug survey more than doubled last month from August prices.

the drug – the generic version of Novartis Diovan – since August, according to the U.S. food and drug administration in deficiency.

it not immediately clear was what manufacturers had raised their prices for the drug. Alembic pharmaceuticals, jubilant pharmaceuticals and Mylan NV are companies that still sell versions of the drug.

it was the price of a Tablet 160 mg of valsartan about 31 cents from 14 cents one month earlier, according to the survey. An 80-milligram tablet costs about 20 cents on average in September, up 9 cents from a month earlier.

that average costs for a 40 mg tablet increased by 47 percent in the month to about 19 cents.

Eric Pachman, co-founder of health data set 46brooklyn, said that the situation of prices for Hydroxychloroquine, the end of 2014 reminded him of the rise after regulatory problems of Indian pharmaceutical company Ranbaxy hit Dolby launched Laboratories. The cost for the malaria drug rose to $2.62 per pill of 10 cents per pill in less than a year.

he said that even short-term increases in the cost of a drug shortage could compromise, how much pay some U.S. consumers for some time.

“If the price of valsartan jumps to $2 and then three weeks later it comes again to 20 cents, there are consumers somewhere in this country on high deductible plans $2 per pill pay still three years from now,” said Pachman.

last month the FDA stopped all imports of medicinal products and manufactured pharmaceutical active ingredients in Huahais Chuannan factory.

Huahai shows English-language website that the company more than 50 drugs, active pharmaceutical ingredients and intermediates, which makes a variety of medications for the treatment of high blood pressure, depression and other conditions. It was not immediately clear how many of these products on the Chuannan system are made.

reporting by Michael Erman, editing by Rosalba O’Brien

our standards:Thomson Reuters trust principles.